
Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2I & SGLT2i+DPP4i combinations
Monday, August 31st 2026 - 2:30 PM (IST)
358 doctors attending
Monday, August 31st 2026 - 2:30 PM (IST)
About this session
This session explores the evolving paradigm of cardio-renal-metabolic care, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations can improve outcomes in patients with type 2 diabetes and associated co-morbidities. It focuses on mechanisms, patient selection, real-world evidence, and practical strategies to achieve comprehensive heart, kidney, and metabolic protection in routine clinical practice.
Faculty
Other details
Registration
Free
Duration
60 min
Replay
Yes
Certificate
No
Language
English
Supported by

Explore other sessions

